Other Events: FWD Pharma   |    Trial Master File Conference   |    Talk to a live representative: 888-409-4418

David Stefanich

Founder and CEO

David Stefanich is the Founder and CEO of Rymedi, which provides blockchain-based, trusted B2B data transmission infrastructure designed to meet the specialized regulatory and business needs of the pharmaceutical and healthcare supply chain.

RYMEDI enables the health sector and other highly regulated industries to capture, track and share data to expand markets and improve performance. Purpose-built for healthcare regulations and standards, the RYMEDI platform includes a data exchange protocol, distributed ledgers and applications for tracking data within and between participants in order to provide actionable, electronic information for end users – whether regulator audits, certificates of analysis, inventory tracking, internal process reports, workflow analytics, IoT integration, digital health activities or a multitude of emerging uses.

David’s career as a results-driven executive with a diverse professional background ranging from hands-on experience within chemical formulation has consistently delivered strategic solutions and global growth.

His ability to draw on enterprise digital technology, leadership and M&A experience have resulted in a track record of impactful transformations and process/platform innovations within the highly-regulated Life Science Sector, Finance, Pharmaceuticals, IoT and blockchain. His passion is to create companies that deliver innovative growth drivers while creating positive Global impact on people.

Copyright © 2020 by Lincoln Health Network | Terms and Conditions | Privacy Policy